CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSE: CRL · Wilmington, MA · Healthcare
$226.58-2.71 (-1.18%)Closed
Market Cap$10.91B
Cash$203.7Mmost recent
Runwayprofitable
P/E (TTM)—EPS $-2.91
52-Wk Range$145.57 – $233.60
Avg Volume921.9K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$226.58+2.2%
Pipeline
Drug candidates sponsored by CRL · ClinicalTrials.gov
Couldn't load pipeline. ClinicalTrials.gov or the backend may be unavailable.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for CRL. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.